Join thought leaders, NGS experts, lab directors, variant scientists, clinicians, and geneticists under one virtual roof at the QIAGEN Digital Insights Second Annual Clinical Hereditary Disease Diagnostics Summit hosted on October 12 (available on-demand) and November 9, 2023 (live session).
The two-part event features important conversations on the opportunities and limitations of using artificial intelligence (AI) in hereditary disease diagnostics. Designed to help diagnostic labs learn how to safely apply AI to exome and genome sequencing workflows, the event will feature discussions on the future of hereditary disease diagnostics and educational presentations on the latest databases and AI-powered software for germline secondary and tertiary analysis.
Dr. Lisa M. Vincent, PhD
Senior Laboratory Director of Organ Health and Genomic Platforms, Natera Inc, USA
Dr. Atil Bisgin, MD, PhD
Medical Geneticist, Department of Medical Genetics, Cukorova University, Turkey
Dr. Ana Krivokuca, PhD
Head, Department Of Genetic Counselling Institute of Oncology and Radiology Serbia
Dr. Dan Richards, PhD
Vice President, Global Clinical Product Management, QIAGEN Digital Insights, USA
Dr. Kathryn Bungartz, PhD
Professional Clinical Solutions Manager, QIAGEN Digital Insights
Iman Bhattacharya, MS
Senior Global Product Marketing Manager, QIAGEN Digital Insights
10:00 - 10:30 am (CEST) | 1:00 - 1:30 pm (EST)
With the increasing demand for speed, flexibility, and cost-efficiency in clinical NGS secondary analysis, diagnostic labs need a simple and seamless way to process more sequencing data without extensive time and resource investment. In this talk, learn about QCI Secondary Analysis, a cloud-based NGS secondary analysis service that requires <1 minute and <$1.00 to process one WES sample.
Leif Schauser, PhD
Director, Global Product Management
QIAGEN Digital Insights
Neha Jalan, PhD
Professional Services Solution Manager
QIAGEN Digital Insights
10:30 - 11:00 am (CEST) | 1:30 - 2:00 pm (EST)
To improve the diagnostics of rare genetic diseases, AI approaches to evidence curation and variant prioritization are becoming commercially available. In this talk, learn about QCI Interpret for Hereditary, a clinical decision support platform that combines the unmatched accuracy and consistency of QIAGEN’s proprietary expert (MD/PhD) curation with the superior efficiency of AI-powered curation to enable high-confidence variant interpretation and reporting of the complete clinical exome.
Georgios Stamoulis, PhD
Director, Global Product Management for Rare and Hereditary Diseases
QIAGEN Digital Insights
11:00 - 11:30 am (CEST) | 2:00 - 2:30 pm (EST)
Clinical diagnostic labs need access to curated, peer-reviewed evidence that will support more precise, comprehensive variant interpretation. In this talk, learn about Human Gene Mutation Database (HGMD) Professional, largest, manually curated resource for finding disease-causing mutations. All attendees will qualify for a free 5-day trial of HGMD Professional.
Tim Bonnert, PhD
Associate Director, Applied Advanced Genomics
QIAGEN Digital Insights
Ruth Burton, PhD
Field Application Scientist
QIAGEN Digital Insights
Araceli Cuellar, PhD
Field Application Scientist
QIAGEN Digital Insights
The 2023 Clinical Hereditary Disease Diagnostics Summit is a unique event for clinical diagnostic labs to explore new solutions, glean meaningful insights and tips, and connect with industry leaders.
